Align Technology Cash Flow from Investing Activities 2010-2024 | ALGN

Align Technology annual/quarterly cash flow from investing activities history and growth rate from 2010 to 2024. Cash flow from investing activities can be defined as the total change in cash resulting from a companies investments
  • Align Technology cash flow from investing activities for the quarter ending December 31, 2024 was $-0.255B, a 30.09% increase year-over-year.
  • Align Technology cash flow from investing activities for the twelve months ending December 31, 2024 was $-0.728B, a 19.33% increase year-over-year.
  • Align Technology annual cash flow from investing activities for 2024 was $-0.255B, a 30.09% increase from 2023.
  • Align Technology annual cash flow from investing activities for 2023 was $-0.196B, a 8.14% decline from 2022.
  • Align Technology annual cash flow from investing activities for 2022 was $-0.213B, a 62.14% decline from 2021.
Align Technology Annual Cash Flow Investing
(Millions of US $)
2024 $-255
2023 $-196
2022 $-213
2021 $-563
2020 $-232
2019 $-350
2018 $7
2017 $-251
2016 $73
2015 $-166
2014 $-202
2013 $-211
2012 $-78
2011 $-212
2010 $-16
2009 $-2
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $12.549B $3.999B
Align Technology manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM (computer-aided design and computer-aided manufacturing) digital services used in dentistry, orthodontics, and dental records storage. The clear aligner system corrects malocclusion using nearly invisible and removable appliances that gently move the tooth to a desired final position. Align Technology has 2 operating segments, Clear Aligner, known as the Invisalign system and the CAD/CAM Services which is known as the iTero intra-oral scanners and OrthoCAD services.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $87.363B 23.91
Becton Dickinson (BDX) United States $57.057B 14.28
Cardinal Health (CAH) United States $32.542B 17.43
Straumann Holding AG (SAUHY) Switzerland $18.704B 0.00
Labcorp (LH) United States $18.166B 14.90
Cooper (COO) United States $15.901B 21.09
West Pharmaceutical Services (WST) United States $14.596B 29.91
Henry Schein (HSIC) United States $7.930B 13.66
Merit Medical Systems (MMSI) United States $5.369B 26.12
Patterson (PDCO) United States $2.772B 15.98
DENTSPLY SIRONA (XRAY) United States $2.557B 7.68
CONMED (CNMD) United States $1.503B 11.68
STAAR Surgical (STAA) United States $0.833B 0.00
Pro-Dex (PDEX) United States $0.198B 30.26
Lifevantage (LFVN) United States $0.169B 18.65